Feature
By Memorial Sloan Kettering  |  Tuesday, June 5, 2012

Memorial Sloan Kettering and IBM have agreed to collaborate on the development of a powerful tool built upon IBM Watson to provide medical professionals with improved access to comprehensive cancer data and practices.

Pictured: Chaya Moskowitz
In the Clinic
By Media Staff  |  Monday, June 4, 2012

A new study confirms that female childhood cancer survivors who were treated with radiation to the chest have a high risk of developing breast cancer at a young age – a risk that is comparable to that of women who have mutations in BRCA1 or BRCA2 genes.

Pictured: Howard Scher
Perspective
By Memorial Sloan Kettering  |  Friday, June 1, 2012

Memorial Sloan Kettering’s prostate cancer team — including Howard I. Scher, Chief of the Genitourinary Oncology Service — disagrees with new PSA screening recommendations released by government task force.

Pictured: Nikola Pavletich and Alexander Rudensky
Honor
By Memorial Sloan Kettering  |  Wednesday, May 30, 2012

Structural Biology Program Chair Nikola P. Pavletich and immunologist Alexander Y. Rudensky have received one of the highest honors given to scientists working in the United States.

Video
By Memorial Sloan Kettering  |  Tuesday, May 29, 2012

Dr. Pusic, a plastic surgeon specializing in breast reconstruction, talks about advances in reconstructive surgery techniques and in measuring quality of life for patients after surgery.

Pictured: Peter Bach
Q&A
By Allyson Collins, MS, Science Writer/Editor  |  Monday, May 21, 2012

In an interview, Dr. Bach talks about research showing that CT screening may prevent one in five cancer deaths for people at a very high risk of developing lung cancer.

Pictured: Robert Motzer
In the Clinic
By Esther Napolitano, BS, Science Writer/Editor  |  Monday, May 21, 2012

Results of an international study indicate that the investigational drug tivozanib is more effective and better tolerated than a currently approved therapy in delaying cancer growth.

Pictured: Graduates
Event
By Memorial Sloan Kettering  |  Friday, May 18, 2012

As part of Memorial Sloan Kettering’s 33rd annual academic convocation on May 11, the Louis V. Gerstner, Jr. Graduate School of Biomedical Sciences awarded PhDs to four graduates.

Pictured: Paul Paik
Finding
By Media Staff  |  Thursday, May 17, 2012

Memorial Sloan Kettering was one of the first centers to use this type of genetic testing for lung cancer patients and is currently one of the only centers testing for mutations in squamous cell carcinomas of the lung.

Pictured: Jonathan Coleman
Video
By Memorial Sloan Kettering  |  Monday, May 14, 2012

Dr. Coleman, who specializes in treating prostate and kidney cancers, talks about how minimally invasive surgical techniques reduce recovery time and pain, as well as improve quality of life for patients.

Pictured: Neural stem cells
Philanthropy
By Memorial Sloan Kettering  |  Friday, May 11, 2012

Research at Memorial Sloan Kettering will benefit from renewed support for The Starr Cancer Consortium and the Tri-Institutional Stem Cell Initiative totaling $105 million.

Pictured: 2012 Rudin Award Winners
Honor
By Memorial Sloan Kettering  |  Wednesday, May 9, 2012

Six nursing staff members were named the 2012 Samuel and May Rudin Award winners at an early morning ceremony today.

Pictured: William Jarnagin
Video
By Memorial Sloan Kettering  |  Monday, May 7, 2012

Dr. Jarnagin – a surgeon who treats patients with disorders of the pancreas, liver, and bile ducts – discusses the specialized expertise of surgeons at Memorial Sloan Kettering, a high-volume center.

Pictured: Valerie Rusch
Video
By Memorial Sloan Kettering  |  Thursday, May 3, 2012

Dr. Rusch, Chief of the Thoracic Service, discusses the multidisciplinary care plan that is developed for each patient by a specialized team of physicians at Memorial Sloan Kettering.

Pictured: At Eternity’s Gate by Vincent van Gogh
In the Clinic
By Eva Kiesler, PhD, Science Writer/Editor  |  Monday, April 30, 2012

Memorial Sloan Kettering researchers have found that people in the late stages of cancer might benefit from meaning-centered psychotherapy, a treatment aimed at helping people sustain a sense of meaning and purpose.

Center News

Stay Informed

Get the latest information about cancer care and research every month.